Catalent, Inc. announced changes to its executive leadership team that went into effect July 1, 2022. Dr. Aris Gennadios was named group president of Catalent's newly formed pharma and consumer health segment. Jonathan Arnold, previously served as president, Oral & Specialty Delivery, since 2017, is Catalent's new senior vice president, chief commercial officer, and head of transformation.

Additionally, Steven Fasman, previously served as senior vice president and general counsel since 2014, will be Catalent's executive vice president and chief administrative officer, a newly created position. Mr. Fasman will oversee certain administrative functions of the company, including legal & compliance, information technology, engineering, procurement, governmental affairs, and various ESG-related departments. Finally, Karen Flynn has announced decision to retire from her role as Catalent's senior vice president and chief commercial officer.